Conformis (NSDQ:CFMS) shares took a hit today on fourth-quarter results that beat the consensus forecast on earnings but came up just shy on sales.
The Billerica, Mass–based orthopedic device maker posted losses of -$5.4 million, or -8¢ per share, on sales of $19.89 million for the three months ended Dec. 31, 2019, for a more than $4 million bottom-line gain on a sales decline of 9.8%.
Adjusted to exclude one-time items, losses per share were also -8¢, 2¢ ahead of Wall Street, where analysts were looking for sales of $19.9 million.
Conformis did not offer guidance on its adjusted EPS for fiscal 2020, but said it anticipates the year’s revenue growth to come in between 3% and 6%.
CFMS shares were down -3.1% at 86¢ per share in early-morning trading today.
